NAD+ Nicotinamide Adenine Dinucleotide — Class II drug recall D-0939-2022
Completed recall by Olympia Compounding Pharmacy dba Olympia Pharmacy, reported 2022-06-01, distributed nationwide. Lack of assurance of sterility.
| Recall number | D-0939-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Olympia Compounding Pharmacy dba Olympia Pharmacy, Orlando, FL, United States |
| Recall initiated | 2022-05-09 |
| Classified | 2022-05-25 |
| Reported by FDA | 2022-06-01 |
| Distributed | Nationwide (US) |
| Quantity | 8,982 vials |
| Reason classes | sterility |
| NDC | 73198-0083-00 |
| Lot numbers | A2401422, K41001, K41130, L24113, L41102 |
| Expiration dates | 2022-11-01, 2022-11-30, 2022-12-02, 2022-12-13, 2023-01-14 |
Product
NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0083-00.
Reason for recall
Lack of assurance of sterility.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0939-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.